May 03, 2023 08:00 AM

Hunan Jingfeng Pharmaceutical Co.,Ltd. Posted 100.9 Million Yuan Net Loss in 2022

00:00

00:00/00:00

Listen to this article 1x

Hunan Jingfeng Pharmaceutical Co.,Ltd. (湖南景峰医药股份有限公司) (000908.SZ) reported a net loss of 100.9 million yuan in 2022, narrowing 50% year-on-year.

Meanwhile, the company posted 840.7 million yuan in revenue, up 3.6% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 85.4%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Huaiyang Cuisine Takes Center Stage at Trump Banquet

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning

00:00

00:00/00:00

MOST POPULAR

1: In Depth: As China’s Hidden Local Debts Shrink, a New Challenge Emerges

2: China Taps Industry Veteran Ding Xiangqun to Lead Top Financial Regulator

3: EU Fines Temu 200 Million Euros for Letting in Unsafe Products

4: China Steps Up Enforcement of Critical Mineral Export Controls

5: China Unveils Sweeping Five-Year Urban Renewal Plan